
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health Inc. is projected to achieve significant revenue growth in its Integrated Care segment, with guidance indicating a rise to $1.613 billion for the full year 2026, reflecting an annual increase of $34 million. The BetterHelp segment is also anticipated to experience a remarkable increase in insurance revenue, forecasted to grow from $13 million in 2025 to between $75 million and $90 million in 2026, thereby enhancing its revenue mix substantially. Additionally, the company's growth trajectory is supported by expanding international markets and a strong adjusted EBITDA forecast of $251.9 million for the Integrated Care segment, marking an increase of $12.6 million year-over-year and indicating strengthened profitability potential.
Bears say
Teladoc Health is facing significant financial challenges, particularly in its BetterHelp segment, which is anticipated to experience a decline in gross margin and a major adjusted EBITDA headwind by 2026 due to changes in revenue mix and membership reduction. The company's overall revenue growth has slowed, leading to lowered targets for BetterHelp that predict low-single-digit growth, indicating a stark contrast to previous performance trends and introducing uncertainty about future profitability. Furthermore, the transition of Integrated Care revenue from fee-based to visit-based models, compounded by expected declines in membership and operational expense cuts, may further dilute Teladoc's value proposition and hinder its growth trajectory.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares